{
    "nctId": "NCT01322893",
    "briefTitle": "Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer",
    "officialTitle": "Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "To determine whether numbers of circulating tumour cells in peripheral blood can give information of prognosis, and to evaluate if the numbers of circulating tumour cells can give information of the efficacy of given treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with metastatic breast cancer\n* ECOG performance status 0-2\n* Age over18 years\n* Signed informed concent\n* Predicted life expectancy over 2 months\n* Planned for first line systemic treatment for metastatic disease (chemotherapy, antibody treatment or endocrine treatment)\n* Standard imaging evaluation within 4 weeks of inclusion\n* Planned for standard imaging within 16 weeks after start of therapy\n\nExclusion Criteria:\n\n* Prior medical therapy for metastatic disease (prior adjuvant chemotherapy, radiotherapy or endocrine therapy is permitted)\n* Inability to understand information about the study\n* Other malignant disease with the exception of curatively treated basal cell or squamous cell cancer of the skin and cancer in situ of the cervix",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}